Literature DB >> 23030267

Comments on the working group's 2012 review of the Program.

Meir Bialer1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 23030267     DOI： 10.1111/j.1528-1167.2012.03682.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN： 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  2 in total

Review 1.  Issues related to development of new antiseizure treatments.

Authors:  Karen S Wilcox; Tracy Dixon-Salazar; Graeme J Sills; Elinor Ben-Menachem; H Steve White; Roger J Porter; Marc A Dichter; Solomon L Moshé; Jeffrey L Noebels; Michael D Privitera; Michael A Rogawski
Journal:  Epilepsia       Date:  2013-08       Impact factor: 5.864

Review 2.  Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion.

Authors:  Roy E Twyman
Journal:  Neurochem Res       Date:  2017-06-07       Impact factor: 3.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.